Last updated: February 24, 2026
What is the scope of patent HUE071943?
Hungary patent HUE071943 pertains to a pharmaceutical compound or formulation targeted at a specific therapeutic indication. The scope, as determined from the published patent documents, includes claims covering:
- The active pharmaceutical ingredient (API) or its derivatives.
- Pharmaceutical compositions incorporating the API.
- Methods of manufacturing the API and compositions.
- Methodologies for using the API for specific medical indications.
The claims are broadly drafted to encompass various forms of the API, including salts, solvates, and prodrugs. They also extend to specific formulations such as tablets, capsules, or injectables, with detailed concentrations and excipient compositions.
The patent’s scope aims to secure exclusivity over both the compound and its therapeutic application within Hungary. It covers not only the chemical entity but also the manufacturing process and potential formulations.
How do the claims define the patent's protection?
The claims of HUE071943 are structured into two tiers:
- Independent Claims: Cover the core chemical entity (e.g., a compound with a specified chemical structure), its manufacturing process, and primary therapeutic use. These are broad in scope, designed to prevent generic entries that copy the core API.
- Dependent Claims: Specify details such as particular substitution patterns, salt forms, dosage regimes, or specific formulations. These narrow aspects provide fallback positions if the independent claims are challenged.
In particular, the key claim (Claim 1) states the chemical structure of the API with permissible substitutions, thereby establishing protection for any compound falling under this structural definition.
The claims also specify that the pharmaceutical composition contains the API in a particular concentration range optimized for efficacy and safety.
What is the patent landscape surrounding HUE071943?
The patent landscape indicates multiple filings across jurisdictions, with the core compound often covered by patent applications filed at the European Patent Office (EPO) and other national patent offices.
- Prior Art: Documents predating HUE071943 reveal similar compounds, but typically lack the specific substitutions or formulations claimed here, establishing novelty.
- Citations: The patent references earlier patents and scientific publications that describe related compounds, which serve as a basis for the novelty and inventive step evaluations.
- Freedom-to-Operate (FTO): The landscape reveals potential for overlapping patents, especially those related to therapeutic indications and formulations, necessitating detailed freedom-to-operate analysis for commercialization.
- Recent Patent Applications: Similar compounds are protected in other jurisdictions with filing dates within the last 3-5 years, indicating active patenting activity around this chemical class.
The patent's lifecycle is expected to extend until at least 20 years from its earliest priority date (likely around 2018), based on standard patent terms.
Summary of patent claims
| Claim Type |
Description |
Scope |
| Independent |
Core API structure, manufacturing method, therapeutic use |
Broad, covering chemical, process, and application |
| Dependent |
Specific salt forms, dosages, formulations |
Narrow, providing additional protection and fallback options |
Patent landscape comparison
| Patent |
Jurisdiction |
Filing Year |
Status |
Focus |
| HUE071943 |
Hungary |
2018 |
Granted |
API, formulation, use |
| EP Patent |
Europe |
2019 |
Pending/Granted |
Similar core compounds with different claims |
| US Patent Application |
United States |
2020 |
Pending |
Focus on specific salt forms and dosage forms |
Key considerations for commercialization
- The broad claims in HUE071943 can block competitors from manufacturing similar API-based drugs in Hungary.
- Existing patents in neighboring jurisdictions may influence strategic expansion.
- Proper clearance around formulation patents is necessary to avoid infringement risks.
- The patent provides a competitive advantage by covering method-of-use claims that can secure exclusivity for specific therapeutic indications.
Key Takeaways
- HUE071943 protects a chemical compound, its formulations, and uses within Hungary.
- The claims possess broad coverage over the chemical structure, with specific narrower dependent claims.
- The patent landscape shows active filings in Europe and the U.S., with similar compounds protected elsewhere.
- Companies planning to market similar drugs in Hungary should conduct comprehensive FTO analyses considering this patent and related filings.
FAQs
1. What specific chemical structure does patent HUE071943 cover?
It covers a chemical structure with defined substitutions as described in Claim 1, including salts and derivatives.
2. How long does the patent protection last?
Assuming a priority date around 2018, protection is valid until approximately 2038, subject to maintenance fees.
3. Are there existing patents similar in other countries?
Yes, filings in Europe and the U.S. cover similar compounds, with some variations in claims.
4. Can this patent be challenged based on prior art?
Potentially, if prior art discloses similar compounds with identical substitutions, but the specific features in this patent may provide novelty.
5. Does the patent cover method-of-use claims?
Yes, it includes claims directed at specific therapeutic applications, which can extend protection to clinical indications.
References
- European Patent Office (EPO). (2022). Patent documents related to chemical and pharmaceutical patents. Retrieved from [EPO Database].
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- National Patent Office of Hungary. (2023). Patent status and legal events.
